speb/financial-data huggingface dataset:
BGH — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Financial Services | Industry: Asset Management
Lynch category:  (confidence: Low)
Market cap (USD): 218898279.9
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
BGH — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Financial Services | Industry: Asset Management
Lynch category: Speculative (confidence: Low)
Market cap (USD): 175319448.03
Net income (USD): -47204909
P/B ratio: 0.6129161216262947
Pays dividend: no
Net asset value (USD): 286041502
Net cash (USD): -107822578
Net cash to market cap %: -61.500637385961774
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 3 (Weak)
BGH — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Financial Services | Industry: Asset Management
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 207451305.63
Net income (USD): 47697927
P/E ratio: 4.349272991046341
P/B ratio: 0.6802055573503353
Pays dividend: no
Net asset value (USD): 304983256
Net cash (USD): -107856655
Net cash to market cap %: -51.99131173094078
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 6 (Neutral)
BGH — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Financial Services | Industry: Asset Management
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 263882880.54000002
Net income (USD): 42061119
EPS growth %: -11.817721134924794
Revenue growth %: -11.399004865589127
Smoothed growth %: -11.817721134924794
P/E ratio: 6.273796009564083
P/B ratio: 0.8326065555085945
Pays dividend: no
Net asset value (USD): 316935867
Net cash (USD): -149642116
Net cash to market cap %: -56.70777721304921
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
BGH — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Financial Services | Industry: Asset Management
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 280551296
Net income (USD): 20087546
EPS growth %: -52.24200763655384
Revenue growth %: -50.074241564274224
EPS 2-year CAGR %: -35.10463344252117
Smoothed growth %: -52.24200763655384
P/E ratio: 14.26
P/B ratio: 0.9450845417891963
Dividend yield: 0.10
Pays dividend: yes
Net asset value (USD): 303015411
Net cash (USD): -137635137
Net cash to market cap %: -49.058813472741896
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 4 (Weak)
BGI — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Consumer Cyclical | Industry: Luxury Goods
Lynch category:  (confidence: Low)
Market cap (USD): 26010010.23
Pays dividend: no
Net asset value (USD): -12102962.962962963
Net cash (USD): -147765925.9259259
Net cash to market cap %: -568.111756278713
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
BGI — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Consumer Cyclical | Industry: Luxury Goods
Lynch category:  (confidence: Low)
Market cap (USD): 13658224.549999999
Pays dividend: no
Net asset value (USD): -14704895.104895106
Net cash (USD): -148658741.25874126
Net cash to market cap %: -1088.4192210673625
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
BGI — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Consumer Cyclical | Industry: Luxury Goods
Lynch category:  (confidence: Low)
Market cap (USD): 13064388.700000001
Pays dividend: no
Net asset value (USD): -17220863.30935252
Net cash (USD): -166587769.78417268
Net cash to market cap %: -1275.1286999304657
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
BGI — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Consumer Cyclical | Industry: Luxury Goods
Lynch category:  (confidence: Low)
Market cap (USD): 10120656
Pays dividend: no
Net asset value (USD): -17710791.366906475
Net cash (USD): -168525899.28057554
Net cash to market cap %: -1665.1677448633325
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 3 (Weak)
BGIN — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Technology | Industry: Computer Hardware
Lynch category:  (confidence: Low)
Pays dividend: no
Net asset value (USD): 154198630.1470588
Net cash (USD): 39763766.17647059
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
BGIN — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Technology | Industry: Computer Hardware
Lynch category:  (confidence: Low)
Pays dividend: no
Net asset value (USD): 114247080.46875
Net cash (USD): -19021143.75
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
BGIN — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Technology | Industry: Computer Hardware
Lynch category:  (confidence: Low)
Market cap (USD): 226271888
P/B ratio: 5.315482492886155
Pays dividend: no
Net asset value (USD): 42572194.53125
Net cash (USD): -9218553.125
Net cash to market cap %: -4.0741044795631
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
BGM — Peter Lynch category analysis (annual, as of 2021-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 7460217816.8
Net income (USD): 487305.71870170016
P/E ratio: 15309.111981439122
P/B ratio: 851.7544146815501
Pays dividend: no
Net asset value (USD): 8180938.639876353
Net cash (USD): -1270084.6986089644
Net cash to market cap %: -0.017024766967913503
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 1551.4662141215824 (Safe Zone)
Piotroski F-score: 2 (Weak)
BGM — Peter Lynch category analysis (annual, as of 2022-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 2196196775.66
Net income (USD): 191890.02808988764
EPS growth %: -60.62224990892188
Revenue growth %: 3.212593764993029
Smoothed growth %: -60.62224990892188
P/E ratio: 11445.080276038256
P/B ratio: 284.4962711769344
Pays dividend: no
Net asset value (USD): 7208597.471910113
Net cash (USD): 667999.0168539328
Net cash to market cap %: 0.030416173279973334
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 982.938587269511 (Safe Zone)
Piotroski F-score: 7 (Neutral)
BGM — Peter Lynch category analysis (annual, as of 2023-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Speculative (confidence: Low)
Market cap (USD): 1495849796.94
Net income (USD): -1065838.3561643837
EPS growth %: -655.4422847158633
Revenue growth %: -30.112422376329324
Smoothed growth %: -30.112422376329324
P/B ratio: 246.2087616502126
Pays dividend: no
Net asset value (USD): 5392952.191780822
Net cash (USD): 2125023.698630137
Net cash to market cap %: 0.14206130207573064
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 950.1970766759357 (Safe Zone)
Piotroski F-score: 5 (Neutral)
BGM — Peter Lynch category analysis (annual, as of 2024-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Speculative (confidence: Low)
Market cap (USD): 3041180630.42
Net income (USD): -205824.53637660487
Revenue growth %: -43.758535104619085
Smoothed growth %: -43.758535104619085
P/B ratio: 483.4896124411915
Pays dividend: no
Net asset value (USD): 5449999.572039943
Net cash (USD): 1316756.3480741798
Net cash to market cap %: 0.04329753829493285
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 1436.5814594203998 (Safe Zone)
Piotroski F-score: 6 (Neutral)
BGM — Peter Lynch category analysis (annual, as of 2025-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Speculative (confidence: Low)
Market cap (USD): 116060584
Net income (USD): -2800736.2359550563
Revenue growth %: 48.75155022335389
Smoothed growth %: 48.75155022335389
P/B ratio: 70.81135444709365
Pays dividend: no
Net asset value (USD): 4991728.230337079
Net cash (USD): -4368332.443820225
Net cash to market cap %: -3.7638380691072735
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 11.79770937603947 (Safe Zone)
Piotroski F-score: 3 (Weak)
BGO.L — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Technology | Industry: Software - Infrastructure
Lynch category: Asset Play (confidence: High)
Market cap (USD): 905370.7054999999
P/B ratio: 0.027663912779772357
Pays dividend: no
Net asset value (USD): -16818750
Net cash (USD): -48656250
Net cash to market cap %: -5374.1798474834795
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
BGO.L — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Technology | Industry: Software - Infrastructure
Lynch category: Asset Play (confidence: High)
Market cap (USD): 981631.8928767124
P/B ratio: 0.027898126676010278
Pays dividend: no
Net asset value (USD): -24412328.76712329
Net cash (USD): -71980821.91780822
Net cash to market cap %: -7332.77132091394
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
BGO.L — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Technology | Industry: Software - Infrastructure
Lynch category: Asset Play (confidence: High)
Market cap (USD): 70284670.27027027
P/B ratio: 0.030846368337730877
Pays dividend: no
Net asset value (USD): -27137837.837837838
Net cash (USD): -66666216.21621622
Net cash to market cap %: -94.85171654054892
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
BHARATSE.NS — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Consumer Cyclical | Industry: Auto Parts
Lynch category: Cyclical (confidence: High)
Pays dividend: no
Net cash (USD): 10721.35038902809
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
BHARATSE.NS — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Consumer Cyclical | Industry: Auto Parts
Lynch category: Cyclical (confidence: High)
Net income (USD): 2624409.2570036543
Pays dividend: no
Net asset value (USD): 17646272.838002436
Net cash (USD): -25627941.534713764
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 4 (Weak)
BHARATSE.NS — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Consumer Cyclical | Industry: Auto Parts
Lynch category: Cyclical (confidence: High)
Net income (USD): 3004484.950233841
EPS growth %: 14.482333203782682
Revenue growth %: -0.07487681964367444
Smoothed growth %: 14.482333203782682
Pays dividend: no
Net asset value (USD): 19866063.077107567
Net cash (USD): -40446684.2547068
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 5 (Neutral)
BHARATSE.NS — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Consumer Cyclical | Industry: Auto Parts
Lynch category: Cyclical (confidence: High)
Market cap (USD): 55031532.267475784
Net income (USD): 3822808.0430208086
EPS growth %: 27.236717984667465
Revenue growth %: 17.750208463711097
EPS 2-year CAGR %: 20.691161002272374
Smoothed growth %: 20.691161002272374
P/E ratio: 14.395578236774217
P/B ratio: 2.419600072453313
PEG ratio: 0.6957356445679025
Pays dividend: no
Net asset value (USD): 22398386.719663315
Net cash (USD): -52513549.2167407
Net cash to market cap %: -95.4244722125914
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 3.0481020530018377 (Safe Zone)
Piotroski F-score: 7 (Neutral)
BHARATSE.NS — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Consumer Cyclical | Industry: Auto Parts
Lynch category: Cyclical (confidence: High)
Market cap (USD): 145180074.26875794
Net income (USD): 4475540.483255616
EPS growth %: 17.074685228479698
Revenue growth %: 37.31994817751232
EPS 2-year CAGR %: 22.04998446357862
Smoothed growth %: 22.04998446357862
P/E ratio: 0.21966596830755936
P/B ratio: 3.808855149558918
PEG ratio: 0.009962182452799265
Dividend yield: 0.01
Pays dividend: yes
Net asset value (USD): 24034569.732937686
Net cash (USD): -51999947.01144553
Net cash to market cap %: -35.8175509093507
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.8108741447605325 (Safe Zone)
Piotroski F-score: 8 (Strong)
BHK — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Financial Services | Industry: Asset Management
Lynch category:  (confidence: Low)
Market cap (USD): 657962680.64
P/B ratio: 1.180640744306656
Pays dividend: no
Net asset value (USD): 557292880
Net cash (USD): -371981165
Net cash to market cap %: -56.53529842120742
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
BHK — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Financial Services | Industry: Asset Management
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 638462140.16
P/B ratio: 0.8788870396385302
Pays dividend: no
Net asset value (USD): 726443913
Net cash (USD): -241834153
Net cash to market cap %: -37.87760272510377
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 2 (Weak)
BHK — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Financial Services | Industry: Asset Management
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 642073408
P/E ratio: 12.87323943661972
P/B ratio: 0.9168370855743835
Dividend yield: 0.10
Pays dividend: yes
Net asset value (USD): 720007314
Net cash (USD): -354010213
Net cash to market cap %: -55.135473388114534
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
BIGG.V — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Financial Services | Industry: Capital Markets
Lynch category:  (confidence: Low)
Market cap (USD): 291348073.0708661
Pays dividend: no
Net cash (USD): 25075615.748031497
Net cash to market cap %: 8.606755309458396
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
BIGG.V — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Financial Services | Industry: Capital Markets
Lynch category: Turnaround (confidence: High)
Market cap (USD): 57552779.70588235
Net income (USD): -32465574.999999996
P/B ratio: 3.385456751179043
Pays dividend: no
Net asset value (USD): 16122239.705882352
Net cash (USD): -28385577.20588235
Net cash to market cap %: -49.32094913737263
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -1.3898390808290626 (Distress Zone)
Piotroski F-score: 2 (Weak)
BIGG.V — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Financial Services | Industry: Capital Markets
Lynch category: Turnaround (confidence: High)
Market cap (USD): 91640514.24242423
Net income (USD): -8384075
Revenue growth %: -10.455410407316105
Smoothed growth %: -10.455410407316105
P/B ratio: 3.7175711481110576
Pays dividend: no
Net asset value (USD): 11258706.06060606
Net cash (USD): -66170759.84848485
Net cash to market cap %: -72.20688403541459
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -0.5681196761422916 (Distress Zone)
Piotroski F-score: 5 (Neutral)
BIGG.V — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Financial Services | Industry: Capital Markets
Lynch category: Turnaround (confidence: High)
Market cap (USD): 42295621.958041966
Net income (USD): -18062706.993006993
Revenue growth %: 76.67486139964532
Smoothed growth %: 76.67486139964532
P/B ratio: 3.449488183699742
Pays dividend: no
Net asset value (USD): 11269048.951048952
Net cash (USD): -145373227.972028
Net cash to market cap %: -343.7075074016902
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -0.7393747652195167 (Distress Zone)
Piotroski F-score: 4 (Weak)
BIGG.V — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Financial Services | Industry: Capital Markets
Lynch category: Turnaround (confidence: High)
Market cap (USD): 15581641.751824817
Net income (USD): -929028.4671532846
Revenue growth %: 7.9923511276381785
Smoothed growth %: 7.9923511276381785
P/B ratio: 1.382688401288844
Pays dividend: no
Net asset value (USD): 10371983.21167883
Net cash (USD): -120867159.12408759
Net cash to market cap %: -775.702336436611
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -0.7502996722676857 (Distress Zone)
Piotroski F-score: 6 (Neutral)
BIIB — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category:  (confidence: Medium)
Market cap (USD): 35421097110.64
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
BIIB — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 40883670439.64
Net income (USD): 3046900000
P/E ratio: 13.418120200741738
P/B ratio: 3.053663652089869
Pays dividend: no
Net asset value (USD): 5798800000
Net cash (USD): -6272900000
Net cash to market cap %: -15.34328971089132
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 4.258692401119363 (Safe Zone)
Piotroski F-score: 3 (Weak)
BIIB — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 38204056766.09
Net income (USD): 1161500000
EPS growth %: -61.87928714431061
Revenue growth %: -3.3204238504334835
Smoothed growth %: -61.87928714431061
P/E ratio: 32.891998937658194
P/B ratio: 2.5814598406752975
Pays dividend: no
Net asset value (USD): 217200000
Net cash (USD): -10995500000
Net cash to market cap %: -28.780974929760937
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 3.568936582703164 (Safe Zone)
Piotroski F-score: 4 (Weak)
BIIB — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 22576667931.64
Net income (USD): 1632200000
EPS growth %: 40.525182953077916
Revenue growth %: -1.6236935214933506
EPS 2-year CAGR %: -26.80901593537972
Smoothed growth %: 40.525182953077916
P/E ratio: 13.832047501311113
P/B ratio: 1.350602293110792
Pays dividend: no
Net asset value (USD): 545900000
Net cash (USD): -8958300000
Net cash to market cap %: -39.67946034873206
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.8522691767166792 (Grey Zone)
Piotroski F-score: 7 (Neutral)
BIIB — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 25982656220.83
Net income (USD): 1292900000
EPS growth %: -20.787893640485237
Revenue growth %: 2.21891503632737
EPS 2-year CAGR %: 5.504955989135785
Smoothed growth %: 5.504955989135785
P/E ratio: 20.09641598022276
P/B ratio: 1.423176910566474
PEG ratio: 3.6506042954537166
Pays dividend: no
Net asset value (USD): 2587200000
Net cash (USD): -7367000000
Net cash to market cap %: -28.353529128765366
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 3.2134641716777974 (Safe Zone)
Piotroski F-score: 6 (Neutral)
BIM.PA — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category:  (confidence: Medium)
Market cap (USD): 12451531159.125002
P/B ratio: 2.8386297584326763
Pays dividend: no
Net asset value (USD): 3106770833.3333335
Net cash (USD): -1155416666.6666667
Net cash to market cap %: -9.279313940598616
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
BIM.PA — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category:  (confidence: Medium)
Market cap (USD): 16070901108.635294
P/B ratio: 3.468921491744331
Pays dividend: no
Net asset value (USD): 3288117647.0588236
Net cash (USD): -1232823529.4117646
Net cash to market cap %: -7.6711537273372805
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 2 (Weak)
BIM.PA — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category:  (confidence: Medium)
Market cap (USD): 9595914240
P/E ratio: 38.326875660443825
P/B ratio: 3.1258127482562106
Pays dividend: no
Net asset value (USD): 3497411764.7058825
Net cash (USD): -1057529411.7647058
Net cash to market cap %: -11.020621749165462
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 3 (Weak)
BIMETAL.NS — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Consumer Cyclical | Industry: Auto Parts
Lynch category: Cyclical (confidence: High)
Pays dividend: no
Net asset value (USD): 27072611.084567606
Net cash (USD): -5921309.125656951
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
BIMETAL.NS — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Consumer Cyclical | Industry: Auto Parts
Lynch category: Cyclical (confidence: High)
Net income (USD): 305140.4592609861
Pays dividend: no
Net cash (USD): 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
BIMETAL.NS — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Consumer Cyclical | Industry: Auto Parts
Lynch category: Cyclical (confidence: High)
Net income (USD): 308066.4016834229
Pays dividend: no
Net asset value (USD): 26301776.946457796
Net cash (USD): -4717243.394902969
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 2 (Weak)
BIMETAL.NS — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Consumer Cyclical | Industry: Auto Parts
Lynch category: Cyclical (confidence: High)
Net income (USD): 495951.32225602627
Pays dividend: no
Net cash (USD): 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
BIMETAL.NS — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Consumer Cyclical | Industry: Auto Parts
Lynch category: Cyclical (confidence: High)
Net income (USD): 222919.95490417135
Pays dividend: no
Net asset value (USD): 25829774.52085682
Net cash (USD): -6180022.547914317
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 3 (Weak)
BIMETAL.NS — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Consumer Cyclical | Industry: Auto Parts
Lynch category: Cyclical (confidence: High)
Net income (USD): 190408.82254650776
EPS growth %: -37.59961461431393
Revenue growth %: 12.938084608790707
Smoothed growth %: -37.59961461431393
Pays dividend: no
Net cash (USD): 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
BIMETAL.NS — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Consumer Cyclical | Industry: Auto Parts
Lynch category: Cyclical (confidence: High)
Market cap (USD): 27053890.63162357
Net income (USD): 402225.5192878338
EPS growth %: 30.564552671073585
Revenue growth %: 33.3074547536038
Smoothed growth %: 30.564552671073585
Dividend yield: 0.02
Pays dividend: yes
Net asset value (USD): 24238490.88596863
Net cash (USD): -6287579.482831709
Net cash to market cap %: -23.240943672190696
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.9990434821153076 (Safe Zone)
Piotroski F-score: 2 (Weak)
BINT.OL — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Financial Services | Industry: Asset Management
Lynch category:  (confidence: Low)
Market cap (USD): 229604120.18586093
Pays dividend: no
Net cash (USD): 23522727.27272727
Net cash to market cap %: 10.244906430113707
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
BINT.OL — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Financial Services | Industry: Asset Management
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 128908102.63360323
Net income (USD): 16518218.62348178
P/E ratio: 7.803995429044117
P/B ratio: 0.5358065014808582
Pays dividend: no
Net asset value (USD): 240587044.53441295
Net cash (USD): -325698380.5668016
Net cash to market cap %: -252.6593549301841
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.2155741138651016 (Distress Zone)
Piotroski F-score: 4 (Weak)
BINT.OL — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Financial Services | Industry: Asset Management
Lynch category: Turnaround (confidence: High)
Market cap (USD): 117809510.39882122
Net income (USD): -7662082.514734774
EPS growth %: -146.38564659655611
Revenue growth %: 45.56177294219273
Smoothed growth %: -146.38564659655611
P/B ratio: 0.42862788272337393
Pays dividend: no
Net asset value (USD): 274852652.25933206
Net cash (USD): -350589390.96267194
Net cash to market cap %: -297.5900585409613
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.5345716774952716 (Distress Zone)
Piotroski F-score: 6 (Neutral)
BINT.OL — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Financial Services | Industry: Asset Management
Lynch category: Asset Play (confidence: High)
Market cap (USD): 262120769.52380955
Net income (USD): 35304.5013239188
Revenue growth %: 1954.5982818188293
EPS 2-year CAGR %: -95.37689842168152
Smoothed growth %: 1954.5982818188293
P/E ratio: 7424.570796761906
P/B ratio: 0.4240310001291816
Pays dividend: no
Net asset value (USD): 38261253.309797
Net cash (USD): -916813768.7555163
Net cash to market cap %: -349.7676931214099
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.8333642382849769 (Distress Zone)
Piotroski F-score: 8 (Strong)
BINT.OL — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Financial Services | Industry: Asset Management
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 379224985.57470125
Net income (USD): 2009950.2487562187
EPS growth %: 5593.18407960199
Revenue growth %: 16.10661914004171
Smoothed growth %: 5593.18407960199
P/E ratio: 188.67381708048256
P/B ratio: 0.6285807997469566
PEG ratio: 0.033732810219596523
Pays dividend: no
Net asset value (USD): -76268656.71641791
Net cash (USD): -962099502.4875622
Net cash to market cap %: -253.7015067795537
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.7854727984671883 (Distress Zone)
Piotroski F-score: 5 (Neutral)
BIOV.SW — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Pays dividend: no
Net asset value (USD): 11868888.888888888
Net cash (USD): 9272222.222222224
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
BIOV.SW — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 254388478.49999997
P/B ratio: 2.912497786046511
Pays dividend: no
Net asset value (USD): 87343750
Net cash (USD): 84030000
Net cash to market cap %: 33.03215636788362
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 3 (Weak)
BIOV.SW — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 202089478.48101264
P/B ratio: 2.3857061142599183
Pays dividend: no
Net asset value (USD): 75710126.58227848
Net cash (USD): 65417721.518987335
Net cash to market cap %: 32.370671650347035
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
BIRD.L — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Technology | Industry: Software - Application
Lynch category: Asset Play (confidence: High)
Market cap (USD): 300169.705
P/B ratio: 0.03182594107789713
Pays dividend: no
Net asset value (USD): 4642096.25
Net cash (USD): 3615950
Net cash to market cap %: 1204.6352245973655
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
BIRD.L — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Technology | Industry: Software - Application
Lynch category: Asset Play (confidence: High)
Market cap (USD): 328953.101369863
P/B ratio: 0.03994787154970665
Pays dividend: no
Net asset value (USD): 2569336.98630137
Net cash (USD): 2187550.684931507
Net cash to market cap %: 665.0038184233149
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
BIRD.L — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Technology | Industry: Software - Application
Lynch category: Asset Play (confidence: High)
Market cap (USD): 9735233.783783784
P/B ratio: 0.013851827364215636
Pays dividend: no
Net asset value (USD): 3443227.027027027
Net cash (USD): 2610731.081081081
Net cash to market cap %: 26.81734346667503
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
BKKT — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Technology | Industry: Software - Infrastructure
Lynch category:  (confidence: Low)
Market cap (USD): 427845262.68
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
BKKT — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Technology | Industry: Software - Infrastructure
Lynch category:  (confidence: Low)
Market cap (USD): 1107390507.48
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
BKKT — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Technology | Industry: Software - Infrastructure
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 387609031.08
Net income (USD): 16239000
P/E ratio: 5.9672552355440605
P/B ratio: 4.752498572567099
Pays dividend: no
Net asset value (USD): -26842000
Net cash (USD): -71777000
Net cash to market cap %: -18.51788638670436
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.1706614823645753 (Grey Zone)
Piotroski F-score: 2 (Weak)
BKKT — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Technology | Industry: Software - Infrastructure
Lynch category: Turnaround (confidence: High)
Market cap (USD): 623661589.8
Net income (USD): -14734000
P/E ratio: 414.393082923588
P/B ratio: 10.785327968871595
Pays dividend: no
Net asset value (USD): -32264000
Net cash (USD): -88822000
Net cash to market cap %: -14.242018660870881
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: -0.2716672838868708 (Distress Zone)
Piotroski F-score: 4 (Weak)
BKKT — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Technology | Industry: Software - Infrastructure
Lynch category: Speculative (confidence: Low)
Market cap (USD): 1504387992.6
Net income (USD): -14918000
P/B ratio: 11.701471583024796
Pays dividend: no
Net asset value (USD): 44186000
Net cash (USD): -66285000
Net cash to market cap %: -4.406110679296312
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 4.130808721094164 (Safe Zone)
Piotroski F-score: 4 (Weak)
BKKT — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Technology | Industry: Software - Infrastructure
Lynch category: Turnaround (confidence: High)
Market cap (USD): 448857516.96
Net income (USD): -85270000
P/B ratio: 3.979868391764643
Pays dividend: no
Net asset value (USD): 42574000
Net cash (USD): -22809000
Net cash to market cap %: -5.081568011711081
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -2.111264936812309 (Distress Zone)
Piotroski F-score: 4 (Weak)
BKKT — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Technology | Industry: Software - Infrastructure
Lynch category: Turnaround (confidence: High)
Market cap (USD): 332619520
Net income (USD): -11650000
EPS growth %: -171.74087074327238
Revenue growth %: -77.14364263489955
Smoothed growth %: -171.74087074327238
P/B ratio: 1.9256016610681306
Pays dividend: no
Net asset value (USD): 100670000
Net cash (USD): 37731000
Net cash to market cap %: 11.343591620840533
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.09278994327973966 (Distress Zone)
Piotroski F-score: 5 (Neutral)
BLAL.NS — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Financial Services | Industry: Shell Companies
Lynch category:  (confidence: Low)
Pays dividend: no
Net cash (USD): 1305.5518923908744
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
BLAL.NS — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Financial Services | Industry: Shell Companies
Lynch category: Speculative (confidence: Low)
Net income (USD): -76492.08282582217
Pays dividend: no
Net asset value (USD): 1045456.7600487211
Net cash (USD): -129866.01705237517
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 3 (Weak)
BLAL.NS — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Financial Services | Industry: Shell Companies
Lynch category: Speculative (confidence: Low)
Market cap (USD): 118199240.64299424
Net income (USD): -446612.30363352917
P/B ratio: 202.85732732139556
Pays dividend: no
Net asset value (USD): 582671.7831874326
Net cash (USD): -569109.0058760043
Net cash to market cap %: -0.48148279361195356
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 117.76108091474278 (Safe Zone)
Piotroski F-score: 3 (Weak)
BLAL.NS — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Financial Services | Industry: Shell Companies
Lynch category: Speculative (confidence: Low)
Market cap (USD): 98505353.07503793
Net income (USD): -438075.7540332008
P/B ratio: 758.0197824791956
Pays dividend: no
Net asset value (USD): 129950.90016366611
Net cash (USD): -1021264.9053074584
Net cash to market cap %: -1.0367608190079727
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 51.0683608648749 (Safe Zone)
Piotroski F-score: 5 (Neutral)
BLAL.NS — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Financial Services | Industry: Shell Companies
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 77639894.87070793
Net income (USD): 1133.9550657058076
P/E ratio: 60345.553166388265
P/B ratio: 576.5155525717456
Pays dividend: no
Net asset value (USD): 118694.36201780416
Net cash (USD): -1267486.2229758373
Net cash to market cap %: -1.632519241668932
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 36.231260502109116 (Safe Zone)
Piotroski F-score: 8 (Strong)
BLAU3.SA — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Low)
Market cap (USD): 951495944.6105264
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
BLAU3.SA — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 766589557.4743834
Net income (USD): 68819696.96969697
P/E ratio: 11.13910103108899
P/B ratio: 2.2264795440674656
Pays dividend: no
Net asset value (USD): 300776515.1515151
Net cash (USD): -7096022.727272719
Net cash to market cap %: -0.9256612822448789
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 5.350154046390793 (Safe Zone)
Piotroski F-score: 3 (Weak)
BLAU3.SA — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 531791463.0062111
Net income (USD): 51507010.309278354
EPS growth %: -25.156586591832603
Revenue growth %: 6.213718070101673
Smoothed growth %: -25.156586591832603
P/E ratio: 10.324642409121063
P/B ratio: 1.2926650235535133
Pays dividend: no
Net asset value (USD): 339670309.27835053
Net cash (USD): -134219587.628866
Net cash to market cap %: -25.239139205079407
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 2.7525968859921566 (Grey Zone)
Piotroski F-score: 4 (Weak)
BLAU3.SA — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 343678754.57350564
Net income (USD): 35146601.941747576
EPS growth %: -31.763459516079994
Revenue growth %: 0.3047512703580888
EPS 2-year CAGR %: -28.53633364442336
Smoothed growth %: -31.763459516079994
P/E ratio: 9.778434772815965
P/B ratio: 0.9875716073102375
Pays dividend: no
Net asset value (USD): 271236731.39158577
Net cash (USD): -124303074.43365696
Net cash to market cap %: -36.168390620454005
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.241499157168328 (Grey Zone)
Piotroski F-score: 7 (Neutral)
BLAU3.SA — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 441649880.54757625
Net income (USD): 54155656.93430656
EPS growth %: 54.085043624031805
Revenue growth %: 9.431476191222705
EPS 2-year CAGR %: 2.538920987193083
Smoothed growth %: 2.538920987193083
P/E ratio: 8.155193853216831
P/B ratio: 1.0729247163020939
PEG ratio: 3.2120707553931593
Pays dividend: no
Net asset value (USD): 301944708.02919704
Net cash (USD): -139452372.2627737
Net cash to market cap %: -31.575322083156625
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.2147216152907037 (Grey Zone)
Piotroski F-score: 5 (Neutral)
BLEE.PA — Peter Lynch category analysis (quarterly, as of 2025-02-28)
Lynch category: Asset Play (confidence: Low)
Market cap (USD): 129057718.5
Pays dividend: no
Net asset value (USD): 264207291.6666667
Net cash (USD): 318750
Net cash to market cap %: 0.24698251581132669
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
BLEE.PA — Peter Lynch category analysis (quarterly, as of 2025-08-31)
Lynch category: Asset Play (confidence: High)
Market cap (USD): 120799123.04651164
P/B ratio: 0.4158017907687875
Pays dividend: no
Net asset value (USD): 287032558.1395349
Net cash (USD): -416373255.8139535
Net cash to market cap %: -344.6823497664268
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
BLEE.PA — Peter Lynch category analysis (quarterly, as of 2026-02-28)
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 144224442.3529412
P/B ratio: 0.573885932969964
Pays dividend: no
Net asset value (USD): 260232941.1764706
Net cash (USD): -455762352.9411765
Net cash to market cap %: -316.0090935389788
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
BLISSGVS.NS — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Low)
Market cap (USD): 165749225.78738657
P/B ratio: 1.3240437359596424
Pays dividend: no
Net asset value (USD): 119680231.72479695
Net cash (USD): -171189.67988533154
Net cash to market cap %: -0.10328234057933017
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
BLISSGVS.NS — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 144964934.1374723
Net income (USD): 1946761.7488894083
P/E ratio: 18.616162740532083
P/B ratio: 1.135718296126734
Pays dividend: no
Net asset value (USD): 121865115.7353285
Net cash (USD): -7957891.045125086
Net cash to market cap %: -5.489528272801825
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 5.378540960791995 (Safe Zone)
Piotroski F-score: 4 (Weak)
BLISSGVS.NS — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 194933943.4776504
Net income (USD): 5190884.624385678
P/E ratio: 9.388281457937437
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
BLISSGVS.NS — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 181860453.98827508
Net income (USD): 3223066.516347238
P/E ratio: 17.552890030418013
P/B ratio: 1.3808164506843084
Pays dividend: no
Net asset value (USD): 126764577.22660653
Net cash (USD): 1572277.339346107
Net cash to market cap %: 0.8645515310587947
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.995743500272272 (Safe Zone)
Piotroski F-score: 2 (Weak)
BLISSGVS.NS — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 192581253.4681965
Net income (USD): 2760287.401136237
P/E ratio: 14.677330173053663
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
BLISSGVS.NS — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 523113069.60576516
Net income (USD): 3921015.260703688
EPS growth %: 101.412179119533
Revenue growth %: 17.6708533720248
Smoothed growth %: 101.412179119533
P/E ratio: 0.18934150830130123
P/B ratio: 1.8476997347457529
PEG ratio: 0.0018670490067877082
Dividend yield: 0.00
Pays dividend: no
Net asset value (USD): 125580150.4874947
Net cash (USD): -7582005.086901229
Net cash to market cap %: -1.4494008135975787
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 13.203733917347412 (Safe Zone)
Piotroski F-score: 3 (Weak)
BLRK — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Financial Services | Industry: Shell Companies
Lynch category:  (confidence: Low)
Pays dividend: no
Net asset value (USD): 166154180
Net cash (USD): -6736056
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
BMA — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Asset Play (confidence: High)
Market cap (USD): 660818670.76
Net income (USD): 1351280872.6139462
P/E ratio: 0.4890313214318637
P/B ratio: 0.14535826982297084
Pays dividend: no
Net asset value (USD): 4385982060.771328
Net cash (USD): -10546370890.144135
Net cash to market cap %: -1595.9553440000227
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 3 (Weak)
BMA — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Asset Play (confidence: High)
Market cap (USD): 839842740.31
Net income (USD): 1563469267.7410235
EPS growth %: 15.702760205331378
Revenue growth %: 68.90449986046538
Smoothed growth %: 15.702760205331378
P/E ratio: 0.5371661328037778
P/B ratio: 0.09311286947442511
PEG ratio: 0.03420838921181513
Pays dividend: no
Net asset value (USD): 8711039779.47413
Net cash (USD): -22290217087.92762
Net cash to market cap %: -2654.094155734433
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 5 (Neutral)
BMA — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Asset Play (confidence: High)
Market cap (USD): 1550913781.47
Net income (USD): 2064817173.692418
EPS growth %: 32.06637420355351
Revenue growth %: -46.0810514417297
EPS 2-year CAGR %: 23.61409315147409
Smoothed growth %: 23.61409315147409
P/E ratio: 0.7511143365281934
P/B ratio: 0.2822553517055453
PEG ratio: 0.031807884033916656
Pays dividend: no
Net asset value (USD): 5290866186.044209
Net cash (USD): -7535711630.238373
Net cash to market cap %: -485.8884949165783
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 4 (Weak)
BMA — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 5858798234.009999
Net income (USD): 416589227.7250771
EPS growth %: -79.82440125775835
Revenue growth %: -42.29310190609115
EPS 2-year CAGR %: -48.38102894018876
Smoothed growth %: -79.82440125775835
P/E ratio: 14.06372955441959
P/B ratio: 1.1335497657486115
Pays dividend: no
Net asset value (USD): 4978288494.442182
Net cash (USD): -9751606599.546062
Net cash to market cap %: -166.4438031495696
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 5 (Neutral)
BMA — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category:  (confidence: Medium)
Market cap (USD): 5492584084.72
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 1 (Weak)
BMR — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Technology | Industry: Software - Application
Lynch category:  (confidence: Low)
Pays dividend: no
Net cash (USD): 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
BMR — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Technology | Industry: Software - Application
Lynch category: Turnaround (confidence: Medium)
Net income (USD): -354545.45454545453
Pays dividend: no
Net asset value (USD): -1393750
Net cash (USD): -1670170.4545454546
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 2 (Weak)
BMR — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Technology | Industry: Software - Application
Lynch category: Speculative (confidence: Low)
Market cap (USD): 22518288.3
Net income (USD): -191988.9502762431
Revenue growth %: -1.20010883765628
Smoothed growth %: -1.20010883765628
P/B ratio: 7.945049088304094
Pays dividend: no
Net asset value (USD): 1547237.5690607734
Net cash (USD): 1340607.7348066298
Net cash to market cap %: 5.953417581951066
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 35.4846485738781 (Safe Zone)
Piotroski F-score: 6 (Neutral)